| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | WO2003070735A3 Components for producing amphoteric liposomes |
| 03/25/2004 | WO2003069350A3 Small molecule modulators of apoptosis |
| 03/25/2004 | US20040059127 Process and intermediates for the preparation of imidazopyridines |
| 03/25/2004 | US20040059121 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin |
| 03/25/2004 | US20040058954 Antiproliferative agents; anticancer agents |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058864 Cyclic peptides; three-dimensional structures; screening; anticancer agents; angiogenesis inhibitors; drug delivery |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | CA2497571A1 Hydantoin derivatives and their use as tace inhibitors |
| 03/24/2004 | EP1400515A1 Cyclic diamine compound having five-membered cyclic group |
| 03/24/2004 | EP1400508A1 Dithiocarbamic acid ester |
| 03/24/2004 | EP1399425A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye |
| 03/24/2004 | EP1399421A1 Substituted imidates as pesticidal agents |
| 03/24/2004 | EP1399417A1 Method for producing perfluoroalkanesulfonic acid esters |
| 03/24/2004 | EP1399167A1 Arylazo-substituted imidazole for the treatment of stress urinary incontinence |
| 03/24/2004 | EP1399163A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 03/24/2004 | EP1399159A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2004 | EP1399158A1 Aromatase inhibitors as novel veterinary drugs |
| 03/24/2004 | EP1399117A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye |
| 03/24/2004 | EP1399116A1 Use of dicationic compounds for dyeing human keratinous fibres and compositions containing same |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | EP1003505B1 Heterocyclic vinylethers against neurological disorders |
| 03/24/2004 | CN1484633A N (phenylsulphonyl) glycine derivatives and their therapentic use |
| 03/24/2004 | CN1483727A Halogenationg agent |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/23/2004 | US6710079 Composition and method for preparing amino acid chelates and complexes free of interfering complex ions |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/18/2004 | WO2004022766A1 PROCESS FOR PRODUCING L-α-METHYLCYSTEINE DERIVATIVE |
| 03/18/2004 | WO2004022546A1 Substances inhibiting biosynthesis of jasmonic acid |
| 03/18/2004 | WO2004022545A1 Protective agents for transplanted organ |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
| 03/18/2004 | US20040054216 Method for producing lysine derivative |
| 03/18/2004 | US20040054212 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
| 03/18/2004 | US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders |
| 03/18/2004 | US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 03/18/2004 | US20040053935 Anticancer agents |
| 03/18/2004 | US20040053934 Anticancer agents |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053932 Peptide deformylase inhibtors |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | US20040053786 Insecticidal 1,8-naphthalenedicarboxamides |
| 03/18/2004 | US20040053382 Oxidizing an alpha-amino-carboxylic acid, hydrate, or salt thereof using a L-amino acid deaminase or oxidase and subsequently reducing the product thereof using a dehydrogenase |
| 03/18/2004 | DE10241555A1 Verfahren zur Durchführung chemischer Reaktionen in der Flüssigphase in Gegenwart eines Katalysators und eines 1,3-substituierten Imidazoliumsalzes A process for carrying out chemical reactions in the liquid phase in the presence of a catalyst and a 1,3-substituted imidazolium salt |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
| 03/17/2004 | EP1398318A1 Process for conducting chemical reactions in a liquid phase in the presence of a catalyst and a 1,3-substituted imidazolium salt |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1244634B1 Substituted benzoylcyclohexane diones for use as herbicides |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | EP1117638B1 Biphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions |
| 03/17/2004 | EP0994106B1 Process for the preparation of carbamoylated imidazole derivatives |
| 03/17/2004 | CN1482120A Process for preparing S,Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound |
| 03/17/2004 | CN1142152C Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof |
| 03/17/2004 | CN1142147C Method for synthesizing hexanolactam by using titanium silicon molecular sieve to catalyze gas phase rearrangement of cyclohexanone-oxime |
| 03/16/2004 | US6706929 Reacting phenol with dimethyl carbonate in presence of 1,4-diazabicyclo(2.2.2)octane catalyst |
| 03/16/2004 | US6706888 Reacting a 3-halotetrahydrofuran or tetrahydropyran compound with formamidine or its salt in the presence of a base to produce a 3-(1h-imidazol-4-yl)propanol derivative; efficiency; intermediates; anticarcinogenic agents; viricides; |
| 03/16/2004 | US6706887 Process for the preparation of alkylimidazolidone (meth)acrylates |
| 03/16/2004 | US6706749 Substituted phenyl derivatives, their preparation and use |
| 03/16/2004 | US6706747 Treating elevated intraocular pressure, depression, non insulin-dependent diabetes, male impotence and obesity which is alleviated by treatment with an alpha 2 blocking agent |
| 03/16/2004 | US6706743 β3 adrenergic receptor agonists and uses thereof |
| 03/16/2004 | US6706739 Treating enterovirus infection |
| 03/16/2004 | US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 03/16/2004 | US6706395 Such as larger particle sized bromochlorodimethylhydantoin |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/11/2004 | WO2004021500A1 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery |
| 03/11/2004 | WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 03/11/2004 | WO2003097587A3 Gelling agents |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003088915A3 Novel sodium channel blockers |
| 03/11/2004 | WO2003084933A3 Method for the production of chiral imidazolidin-2-ones |
| 03/11/2004 | WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | US20040049020 Especially for dyeing paper; red dyeings with good fastness |
| 03/11/2004 | US20040048913 Substituted biaryl amides as C5a receptor modulators |
| 03/11/2004 | US20040048911 Angiotensin II antagonists for treating cardiovascular disorders, hypertension, congestive heart failure and glaucoma. |
| 03/11/2004 | US20040048879 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | US20040048346 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 03/11/2004 | CA2497109A1 Nonaqueous electrolyte and nonaqueous electrolyte secondary battery |
| 03/11/2004 | CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395567A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 03/10/2004 | EP1395286A2 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP1303249B1 Antimycotic nail varnish composition |
| 03/10/2004 | EP1081132B1 Hydroxamic acid derivatives and medicinal utilization thereof |
| 03/10/2004 | EP0804435B1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1480451A Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative |
| 03/09/2004 | US6703507 Nonaqueous liquid comprising the ammonium salt of a sulfonated or carboxylated phosphite ligand; use as a media for chemical reactions, including those using transition metal catalysts |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |